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ABSTRACT The structural transition from the cellular prion protein (PrPC) that is rich in -helices to the pathological form
(PrPSc) that has a high -sheet content seems to be the fundamental event underlying the prion diseases. Determination of
the structure of PrPSc and the N-terminally truncated PrP 27-30 has been complicated by their insolubility. Here we report the
solubilization of PrP 27-30 through a system of reverse micelles that yields monomeric and dimeric PrP. Although solubili-
zation of PrP 27-30 was not accompanied by any recognizable change in secondary structure as measured by FTIR
spectroscopy, it did result in a loss of prion infectivity. The formation of small two- and three-dimensional crystals upon
exposure to uranyl salts argues that soluble PrP 27-30 possesses considerable tertiary structure. The crystals of PrP 27-30
grown from reverse micellar solutions suggest a novel crystallization mechanism that might be applicable for other membrane
proteins. A variety of different crystal lattices diffracted up to 1.85 nm by electron microscopy. Despite the lack of measurable
biological activity, the structure of PrP 27-30 in these crystals may provide insight into the structural transition that occurs
during PrPSc formation.
INTRODUCTION
Scrapie of sheep, bovine spongiform encephalopathy, and
Creutzfeldt-Jakob disease of humans are all caused by PrPSc
(Prusiner, 1997). Spectroscopic analysis has shown that
PrPC contains mostly -helices and is almost devoid of
-sheet, whereas PrPSc and PrP 27-30, which is N-termi-
nally truncated at approximately residue 90, are dominated
by -sheet structure (Caughey et al., 1991; Gasset et al.,
1993; Pan et al., 1993; Prusiner et al., 1983; Safar et al.,
1993). Replication of prions features a profound change in
the conformation of PrP. Current hypotheses on the mech-
anism for nascent PrPSc formation include the template-
assistance model (Cohen and Prusiner, 1998) and the seeded
nucleation hypothesis (Gajdusek, 1988; Jarrett and Lans-
bury, 1993). Prion strain-specified information is enci-
phered in the conformation of PrPSc, arguing that PrPSc
must act as a template in the formation of nascent PrPSc
(Bessen and Marsh, 1994; Safar et al., 1998; Telling et al.,
1996b).
The seeded nucleation hypothesis argues for a crystalli-
zation-like mechanism where seeds consisting of ordered
polymers initiate polymerization. Despite the demonstration
that PrP amyloid is neither necessary nor sufficient for
infectivity (Gabizon et al., 1987; McKinley et al., 1991; Pan
et al., 1993; Prusiner et al., 1990; Wille et al., 1996),
proponents of seeded nucleation hypothesis persist
(Caughey and Chesebro, 1997; Caughey et al., 1997). Al-
though large polymeric structures can be excluded from
being essential for prion formation, oligomers may serve as
a template (for reviews see Cohen and Prusiner, 1998;
Eigen, 1996; Harper and Lansbury, 1997; Harrison et al.,
1997; Safar, 1996).
The scrapie agent’s hydrophobic nature and propensity to
aggregate impeded attempts to purify it (Millson et al.,
1976; Prusiner et al., 1978). Multiple attempts to separate
prion infectivity from membranes were unsuccessful (Hunter
et al., 1968; Hunter and Millson, 1967; Malone et al., 1978;
Marsh et al., 1984; Prusiner et al., 1980; Safar et al., 1991),
in accord with the association of PrPSc with membranes.
Because of difficulties in solubilizing, structural studies of
both PrPSc and PrP 27-30 have been elusive. PrP 27-30
readily polymerizes into large rod-shaped aggregates with
the tinctorial properties of amyloid (Prusiner et al., 1983),
but the prion rods are an artifact of the purification proce-
dure (McKinley et al., 1991). Although solubilization of
purified PrP 27-30 using a combination of detergent and
phospholipid to form DLPCs increased prion titers (Gabi-
zon et al., 1987, 1988), DLPCs interfered with crystalliza-
tion. Solubilization of PrP 27-30 with the denaturing deter-
gent SDS, even at low concentrations, resulted in
diminished prion infectivity (Prusiner et al., 1983; Riesner
et al., 1996). Treatment of prion rods with 0.1% SDS and
sonication produced spherical particles of 10 nm in diam-
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eter that were unsuitable for crystallization (Riesner et al.,
1996). Other reports showed little, if any, solubilization
with the infectious prions migrating with a sedimentation
coefficient of 120 S (Akowitz et al., 1990; Kimberlin et
al., 1971; Sklaviadis et al., 1992).
On this background, we initiated studies employing or-
ganic solvents in combination with a variety of nondena-
turing detergents for solubilization of PrP 27-30 that was
polymerized into prion rods. Through a process of liquid-
liquid extraction via reverse micelles (Go¨klen and Hatton,
1987; Wolbert et al., 1989) and an organic phase, PrP 27-30
was solubilized into predominantly monomers and dimers.
Although solubilization of PrP 27-30 was not accompanied
by any recognizable change in secondary structure as mea-
sured by FTIR spectroscopy, it did result in a loss of prion
infectivity. Small two- and three-dimensional crystals were
formed upon exposure of soluble PrP 27-30 to uranyl salts
directly from the reverse micellar solutions. This finding, as
well as the preservation of secondary structure, argues that
soluble PrP 27-30 possesses considerable tertiary structure.
To our knowledge, this is the first time that a membrane or
membrane-associated protein has been crystallized from
reverse micelles. Electron microscopy showed multiple
crystal forms, and electron diffraction revealed reflections
up to 1.85 nm.
MATERIALS AND METHODS
Materials and solvents
The solvents and detergents used in this study were purchased from the
following sources: AOT, Sigma, St. Louis, MO; APFO, Fluka Chemie,
Buchs, Switzerland; HFIP, Aldrich, Milwaukee, WI; HFPIP, Aldrich;
isooctane, Fluka Chemie; NFBSA, Aldrich; saponin, Calbiochem/Behring
Diagnostics, La Jolla, CA; TFIP, Narchem, Chicago, IL. All solvents were
of the highest purity commercially available. Salts and heavy metal com-
pounds for negative staining and crystallization assays were obtained from
the following sources: ammonium molybdate, Electron Microscopy Sci-
ences, Fort Washington, PA; aurothioglucose, bismuth nitrate, bismuth
oxynitrate, cadmium iodide, copper sulfate, lanthanum nitrate, lead acetate,
and thallium acetate, Sigma; uranyl acetate, Fluka Chemie; uranyl formate,
Polysciences, Warrington, PA; uranyl nitrate, Fluka Chemie; vanadylsul-
fate, SPI supplies, West Chester, PA; zinc sulfate, Sigma. All salts and
negative staining compounds were of the highest purity commercially
available.
Prion protein
PrP 27-30 was prepared as described previously (Prusiner et al., 1983). The
last step of preparation included a sucrose gradient centrifugation in a zonal
rotor. Before the solubilization assays, PrP 27-30 was precipitated out of
the sucrose by dilution and an ultracentrifugation step (Beckman rotor
SW28, 24,000 rpm, 4°C, 16 h). The protein pellet was resuspended in 50
mM NaHEPES, 0.5 mM NaN3 pH 7.4 at a protein concentration of 1
mg/ml or above and kept frozen until use.
Solubilization assay
PrP 27-30 was used mostly in concentrations ranging from 100 to 500
g/ml. Standard buffer was 50 mM NaHEPES, 1 mM PMSF, 0.5 mM
NaN3 pH 7.4 unless indicated otherwise. Detergents were used at concen-
trations of 5 to 10 times the critical micelle concentration (w/v) and organic
solvents were added at concentrations up to and well above the limits of
miscibility with aqueous buffers (v/v). Solubilization assays were incu-
bated at 37°C for 4 h (shorter incubation periods proved to be less
successful) with frequent agitation in order to keep PrP 27-30 in suspension
and the multiple liquid phases mixed. The incubation was followed by an
ultracentrifugation at 100,000  g for 1 h (Beckman rotor TLA 45 43,000
rpm 20°C). After centrifugation, the samples were separated into superna-
tant and pellet; the supernatant could often be differentiated into an organic
and an aqueous phase with or without particles at the interphase. Pellets
were resuspended in 50 mM NaHEPES, 0.5 mM NaN3 pH 7.4. Small
aliquots of pellets and supernatants were used for SDS gel electrophoresis,
bioassays, and negative stain electron microscopy. The remaining sample
was stored at 4°C, and no substantial changes were observed during periods
of up to 6 months, provided appropriate storage vials were used. Isooctane-
containing samples required storage in glass vials because the solvent
evaporated through the plastic walls of conventional tubes.
SDS-PAGE and Western blotting
SDS gel electrophoresis was performed with 15% polyacrylamide gels.
The gels were blotted onto polyvinylidene difluoride membranes. Mem-
branes were saturated with 5% nonfat dry milk in TBST (10 mM Tris HCl
pH 8.0, 150 mM NaCl, 0.05% (v/v) Tween 20) for 1 h at RT. The -PrP
polyclonal antiserum (N10) was used at 1:4000 dilution in TBST in an
overnight incubation at RT (H. Serban et al., manuscript in preparation).
The primary antibody was detected by using a horseradish peroxidase-
coupled secondary antibody and the ECL system (Amersham, Little Chel-
font, Buckinghamshire, UK).
Bioassays
Bioassays were performed by inoculating 50-l samples intracerebrally
into weanling female hamsters (LVG/LAK) purchased from Charles River
Laboratories. Samples were diluted 100-fold into phosphate buffered saline
with 5 mg/ml bovine serum albumin as a carrier. Prion titers were deter-
mined by measuring the incubation time intervals from inoculation to the
onset of neurological illness (Prusiner et al., 1980).
Negative stain electron microscopy, electron
diffraction, and crystallization of PrP 27-30
Negative staining was done on carbon-coated 1000-mesh copper grids that
were glow-discharged before staining. One- to 5-l samples were adsorbed
for up to 1 min, and all samples were then stained with freshly filtered 2%
ammonium molybdate or 2% uranyl acetate. Dried samples were viewed in
a Jeol 100CX II electron microscope at 80 kV at a standard magnification
of 40,000. The magnification was calibrated using negatively stained
catalase crystals and ferritin. Electron diffraction was done with a camera
length of 2.4 m and a diffraction aperture of 0.3 m, covering nonrelevant
objects as much as possible. Exposure times for the electron diffractograms
were in the order of minutes, practically destroying all high-resolution
information. The length of the exposure time and the presence of uranyl
ions within the crystal lattice limit the resolution practically to that of
optical diffraction methods. Crystallization of PrP 27-30 was first observed
after negative staining with 2% unbuffered uranyl acetate solution (pH
3.8) while unbuffered 2% ammonium molybdate (pH 5.4) yielded no
such crystals. Buffered 2% ammonium molybdate, 50 mM sodium acetate
pH 4.0 did not induce PrP 27-30 to crystallize, while the use of buffered
uranyl acetate (2% uranyl acetate, 50 mM sodium acetate pH 4.0) im-
proved the quality of the crystals. Unbuffered saturated uranyl formate
(1% uranyl formate, pH 3.5) and unbuffered 2% uranyl nitrate (pH
2.8) gave equally well-formed but smaller PrP 27-30 crystals. A large
number of other salts and negative stain agents were tested, but none
induced the formation of PrP 27-30 crystals (see Results).
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Dynamic light scattering
Hydrodynamic radii were measured with a DynaPro-801 TC dynamic light
scattering instrument with a MicroCell attachment and Dynamics 3.3
software (Protein Solutions Inc., Charlottesville, VA). The instrument
calibration was checked with a 2 mg/ml aqueous solution of bovine serum
albumin. We measured hydrodynamic radii of soluble particles in the
organic phases after solubilization with 20% TFIP  1% AOT and 20%
isooctane  2% AOT with and without protein. Refractive indices and
densities for TFIP and isooctane were used as published (Timmermans,
1950). Samples were filtered with centrifuge filters with a 0.2 m nylon
membrane (Osmonics, Livermore, CA) before dynamic light scattering
measurements.
Proteinase K digestion assays
Vials containing PrP 27-30 solubilization samples were left open overnight
at RT to remove organic solvents that have been found to inactivate PK
(Wille et al., 1996). After evaporation of the solvents, the samples were
resuspended to the original volume by addition of water, and PrP 27-30
concentrations were kept at the levels achieved by solubilization (Figs. 1
and 5). PK was added to a concentration of 87.5 g/ml. The reaction mix
was incubated at 37°C for 2 h. The reaction was stopped by adding 5 mM
PMSF and one-half volume of SDS sample buffer. All samples were boiled
for 5 min at 100°C before gel electrophoresis.
FTIR
FTIR analysis of PrP 27-30 after solubilization was carried out on samples
with up to 1 mg/ml protein in D2O-containing buffers. Solubilization
assays were performed as in previous experiments except for the use of
D2O instead of H2O. FTIR spectra were recorded with a Perkin-Elmer
(Norwalk, CT) System 2000 FTIR spectrophotometer with a microscope
attachment. The sample was enclosed between 2 AgCl windows (Interna-
tional Crystal Laboratories, Garfield, NJ), creating a pathlength of 50 m
within an airtight sealed chamber. Spectra were recorded in the amide 1
region between 1750 cm1 and 1550 cm1. Blank controls identical in the
concentrations of detergents and solvents were used to subtract any non-
protein contributions from the spectra. Spectral analysis and self-deconvo-
lution were carried out as previously described (Byler and Susi, 1986) and
modified (Gasset et al., 1993).
Sucrose gradient ultracentrifugation
The gradients were produced using a Beckman SW 60Ti rotor at 60,000
rpm and 20°C. The centrifugation was set to reach an 	2dt of 1.25  1012
rad2/s; the value was chosen to pellet particles with a density of 1.3 g/ml
and an S20,w value of 8 S and above. Linear gradients contained 5–20%
sucrose with 10 mM NaHEPES, 50 M NaN3 pH 7.4 with or without 1%
TFIP, and 0.5% AOT. The gradient volume was 4 ml with a 400-l sample
carefully layered onto the top of the sucrose gradient. PrP 27-30 samples
were solubilized by 20% TFIP 1% AOT. The high density of TFIP made
it necessary to dilute the PrP 27-30 sample by a factor of 4 with 10 mM
NaHEPES, 50 M NaN3, pH 7.4. This dilution step reduced the PrP 27-30
concentration and the scrapie titer considerably but was necessary to
prevent the mixing of the sucrose gradient with the sample before centrif-
ugation. After the centrifugation run, the gradients were harvested from the
top into 250-l aliquots. The sedimentation coefficients were calculated
(Steensgaard et al., 1978). The specific volume for PrP 27-30 was calcu-
lated (Durchschlag, 1986), assuming that PrP 27-30 contained 77% protein
(16,240 Da; aa 90–231) with a specific volume of 0.71 cm3/g; 14% lipid
[2975D in the GPI anchor (Stahl et al., 1992)] with a specific volume of
1 cm3/g and 9% polysaccharide [1955 Da (Endo et al., 1989)] with a
specific volume of 0.61 cm3/g. Taken together, PrP 27-30 should have a
specific volume of 0.74 cm3/g (or a density of 1.35 g/ml). The
influence of potentially bound AOT molecules on the density of PrP 27-30
was not taken into account in this estimation. We performed an indepen-
dent calculation of sedimentation coefficients that employs standard pro-
teins with known S20,w values such as ribonuclease A with 1.6 S and
ovalbumin with 3.6 S (Steensgaard et al., 1992) and compares the distances
ribonuclease A, ovalbumin, and PrP 27-30 migrated in the sucrose gradient.
RESULTS
Solubilization assays
In an earlier study, we reported that -helix-promoting
solvents such as HFIP or TFIP disrupt polymers of PrP
27-30 (prion rods) into smaller, more regular structures
FIGURE 1 Western blots of PrP 27-30 after solubilization by organic
solvents, detergents, or combinations. Samples were centrifuged at
100,000  g for 1 h and then separated into pellet and supernatant
fractions. The supernatants were split into organic and aqueous phases
wherever applicable, with the top phase labeled S1 and the bottom phase
labeled S2. The S2 phases of solubilization samples 1% AOT and 2%
NFBSA in 1% LDAO showed considerable viscosity, warranting the term
detergent pellet more than supernatant 2. The control (buffer only) showed
all PrP 27-30 in the pellet. Some organic solvents alone, such as TFIP and
HFPIP, showed considerable solubilization, while detergents alone (AOT,
APFO, and saponin) resulted in less solubilization. Combinations of sol-
vents and detergents gave the best results as judged by ultracentrifugation.
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(Wille et al., 1996). This partial disaggregation seems to
have been caused by the conversion of intermolecular an-
tiparallel -sheets into -helical structures, a process that
could be visualized by a reduction in Congo red dye binding
corresponding to the decrease of amyloid character. In the
investigations reported here, we set out to use these prop-
erties to solubilize the highly aggregated PrP 27-30, thereby
making it practical to attempt crystallization as well as other
biophysical and biochemical methods.
Of a large number of solvents and detergents tested, only
a few yielded any solubilization of PrP 27-30 as judged by
ultracentrifugation at 100,000  g for 1 h (Table 1). The
most promising conditions using solvents or detergents
alone were then combined to test whether any of those were
sufficient to overcome the -sheet and hydrophobic inter-
actions observed in these aggregates. Fig. 1 A shows that
untreated PrP 27-30 (control) was pelleted owing to its
aggregated nature. Organic solvents and detergents alone
led at best to a limited amount of PrP 27-30 in the super-
natants, and only combinations of some solvents and deter-
gents resulted in a virtually complete solubilization (Fig. 1,
A–C). Early on we observed that the best results were
achieved with conditions that caused a separation into two
liquid phases, either during the incubation at 37°C or later at
the 100,000  g ultracentrifugation. Consistently, PrP
27-30 was found primarily in the organic phase and at the
interphase. The organic phase was at the bottom of the tube
for TFIP and HFPIP because of the high density of the
fluorinated alcohol, while the low-density isooctane caused
the organic phase to float above the aqueous buffer. Repeat-
edly, we observed that insoluble protein did not pellet, but
remained trapped at the interphase because of the high
density of the organic phase. We avoided contamination of
the organic phase for further experiments by carefully sep-
arating the phases after ultracentrifugation. We found that
negative stain electron microscopy of the supernatants was
useful in determining whether solubilization had occurred
or aggregates of PrP 27-30 were floating.
Solubilization of a protein or hydrophilic molecule into a
hydrophobic organic solvent is usually achieved through
reverse micelles. Because the detergent AOT is frequently
used in studies of reverse micelles, we tested whether sol-
ubilization occurred via this mechanism as well. Contrary to
solubilization in aqueous systems, the solubilization in re-
verse micelles through AOT is favored at about one pH unit
below the IEP of the protein and decreases at pH values
further away from the IEP (Go¨klen and Hatton, 1987; Wol-
bert et al., 1989). Subsequently we found that PrP 27-30 is
preferentially solubilized at pH 8.0 (with its IEP near pH
9.0) with a decrease in solubilization at lower pH and at pH
values around and above the IEP of PrP 27-30 (data not
shown). Therefore, it appears that PrP 27-30 is solubilized
by reverse micelles formed by the detergent AOT in the
solvents TFIP, HFPIP, or isooctane, respectively. The sol-
ubilization through isooctane  AOT was less reproducible
than the other conditions tested. We investigated the cause
of these problems and observed that hydrolysis products of
aged AOT solutions had a pronounced negative effect on
TABLE 1 Effects of some solvents, detergents, and combinations used for solubilization of PrP 27-30
Solubilizing agent
% Solubilized
(100,000  g supernatant)
Electron microscopy of
supernatant
TFIP (5–20%) up to75% small aggregates
HFIP (1.25–25%) up to20% small aggregates
HFPIP (1.25–10%) up to75% rod fragments
Dimethylsulfoxide (5–20%) 5% n.d.*
AOT (0.25–2%) up to50% rods and rod fragments
Saponin (0.25–1%) up to10% rods and rod fragments
APFO (0.5–5%) up to30% amorphous aggregates
LDAO (0.25–1%) up to5% n.d.
Digitonin (0.25–1%) 0 n.d.
2.5% NFBSA in 1% AOT up to10% rods and rod fragments
2% NFBSA in 1% LDAO up to50% no aggregates detectable
15–20% TFIP  1% AOT up to75% no aggregates detectable
15% TFIP  1% AOT  25% sucrose 
90% no aggregates detectable
15% TFIP  1% AOT  1% APFO 10% n.d.
15% TFIP  1% AOT  2.5% NFBSA 10% n.d.
15% TFIP  1% LDAO  2% NFBSA 
90% no aggregates detectable
15% TFIP  1% saponin 
90% no aggregates detectable
10% HFPIP  1% AOT 10% n.d.
10% HFPIP  1% AOT  25% sucrose 10% rod fragments
10% HFPIP  1% AOT  1% APFO 
90% no aggregates detectable
10% HFPIP  1% AOT  2.5% NFBSA viscous phase# n.d.
10% HFPIP  1% LDAO  2% NFBSA 
90% some rod fragments
10% HFPIP  1% saponin 
90% saponin micelles only
10% HFPIP  2% APFO 
90% rod fragments
20% Isooctane  2% AOT up to80% no aggregates detectable
*n.d., not determined.
#The increased viscosity prevents proper separation.
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solubilization via isooctane AOT and much less so on the
other combinations. The hydrolysis product 2-ethylhexanol
effectively abolished the solubilizing action of isooctane 
AOT, while another major hydrolysis product, sulfosuccinic
acid, had a beneficial effect (data not shown). The deter-
gents saponin or NFBSA/LDAO are not usually known to
form reverse micelles, but we think this solubilization
mechanism could apply here as well.
Negative staining allowed us to check the aggregation
state of solubilized proteins found in the supernatant frac-
tions. Organic solvents such as TFIP or HFPIP alone re-
duced the aggregate size, but did not fully solubilize PrP
27-30 (Fig. 2, B and C). Detergents alone influenced the
structure of PrP 27-30 aggregates even less, barely changing
rod shape and ultrastructure (Fig. 2, D–F). Only combina-
tions of solvents and detergents led to a complete disap-
pearance of rod-shaped aggregates (Fig. 2, A and G–J). The
“doughnut”-shaped structures in Fig. 2 J are saponin mi-
celles that have been described elsewhere (Bomford et al.,
1992; Kersten et al., 1991). Electron microscopy revealed
that solubilization occurred only in conditions when -he-
lix-promoting solvents and detergents were used together.
The widely used solubilization criterion of a 1-h ultracen-
trifugation at 100,000  g was clearly insufficient to judge
solubilization of PrP 27-30 (compare Riesner et al., 1996).
Dynamic light scattering of solubilized PrP
The use of dynamic light scattering allowed us to confirm
our notion that PrP 27-30 is solubilized into reverse mi-
FIGURE 2 Negative stain electron microscopy of PrP 27-30 before and after solubilization. (A) Highly aggregated prion rods. (B) Organic phase
(supernatant 2) of PrP 27-30 “solubilized” by 15% TFIP showing amorphous aggregates of various sizes. (C) PrP 27-30 treated with 10% HFPIP
(supernatant 2) yields small linear polymers. (D) Treatment with 1% AOT changed the rod structure but did not disaggregate PrP 27-30 polymers. 1% APFO
(E) or 1% saponin (F) had little effect on rod structure. The electron micrographs (B–F) show that in all cases, neither solvents nor detergents alone truly
solubilized PrP 27-30, but only prevented the aggregates from pelleting during ultracentrifugation. (G) The combination of 15% TFIP 1% AOT 12.5%
sucrose truly solubilized PrP 27-30, as no protein aggregates could be detected by negative stain electron microscopy (supernatant 2). (H) Supernatant 2
after treatment with a combination of 10% HFPIP  1% AOT  1% APFO was void of protein aggregates as well. Even the combinations of 15% TFIP
 1% saponin (I) and 10% HFPIP 1% saponin (J) showed no apparent protein aggregates. The latter combination showed small doughnut-shaped saponin
micelles, which can be seen in the top view and occasionally (arrowheads) from the side. Negative stain 2% ammonium molybdate. Bar  100 nm.
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celles. Solubilization controls consisting of TFIP  AOT
without protein showed two peaks with a very narrow
distribution: water-filled reverse micelles with a hydrody-
namic radius of 5.3 nm and detergent aggregates with a
hydrodynamic radius of 0.9 nm. Upon solubilization of
PrP 27-30, the pool of reverse micelles became polydis-
persed and disproportionated into smaller water-filled re-
verse micelles and larger reverse micelles that contain pro-
tein (data not shown). A similar behavior has been described
for the uptake of proteins into AOT  isooctane reverse
micelles (Zampieri et al., 1986). PrP 27-30 solubilized into
isooctane  AOT revealed the presence of unexpectedly
large reverse micelles with a hydrodynamic radius of 46
nm (data not shown). Blank control samples under identical
conditions could not be measured with dynamic light scat-
tering because of the presence of very large particles
(presumably detergent aggregates) that interfered with
measurements.
Crystallization of solubilized PrP
While examining negatively stained preparations of solubi-
lized PrP 27-30 by electron microscopy, we found that
under some conditions, PrP crystallized into microscopic
two- and three-dimensional crystals (Fig. 3). Formation of
these crystals was found to require uranyl salts containing
acetate, formate, or nitrate. Other metal salts used for neg-
ative staining such as ammonium molybdate, sodium phos-
photungstate, copper sulfate, zinc sulfate, bismuth oxyni-
trate, bismuth nitrate, thallium acetate, lead acetate,
cadmium iodide, lanthanum nitrate, vanadylsulfate, and au-
rothioglucose did not promote the formation of PrP crystals.
Blank controls that lacked PrP 27-30, but were otherwise
treated identically, did not show any crystalline arrays, but
revealed micelles of various shapes and large detergent
aggregates (data not shown).
In our characterization of the conditions for crystal
growth we found that an acidic pH of 4.0 or lower was
essential. A pH close to 4.0 promoted the growth of two-
dimensional crystals (Fig. 3 B), while pH values at 3.5 or
lower increased the number and size of three-dimensional
crystals (Fig. 3 A). We used 50 mM sodium acetate as a
buffer and found that 50 mM sodium citrate did not support
the growth of PrP 27-30 crystals. During the process of
negative staining it was essential for the reproducible
growth of crystals that some detergent be removed by
washing with uranyl solution. However, excess washing
destroyed all crystals that formed intermittently; this sug-
gests that some amount of detergent is probably required to
maintain crystalline order. Interestingly, we infrequently
observed almost identical protein crystals grown from PrP
27-30 in 15% TFIP  1% LDAO  2.5% NFBSA, which
shows that the detergent AOT was not essential for crystal
growth (data not shown).
PrP 27-30 solubilized by different combinations of deter-
gents and solvents produced several types of crystals (Fig.
3, A and B versus E and F). Lattice spacings were deter-
mined from electron micrographs and by electron diffrac-
tion (compare Table 2 and Fig. 4). The three-dimensional
crystals obtained from TFIP  AOT seemed to be seeded
by underlying two-dimensional arrays, as could be seen by
tilted specimens (Fig. 3, C and D). PrP 27-30 solubilized by
HFPIP  AOT  APFO resulted in arrays with a distinct
crystal lattice (Fig. 3 E and Table 2). Crystals grown from
PrP 27-30 in isooctane  AOT show a high contrast, which
indicates multiple layers and a pronounced tendency to
grow in three dimensions (Fig. 3 F and Fig. 4). In this
preparation, at least four different types of crystals could be
observed; it is conceivable that these represent views from
different directions.
Prion infectivity and PK resistance of
solubilized PrP
Bioassays of PrP 27-30 from solubilization experiments
showed that substantial amounts of infectivity could be
found in the supernatant fractions after treatment with or-
ganic solvents or detergents alone. Solubilization by com-
binations of TFIP AOT sucrose or TFIP saponin led
to a titer in the organic phase (S2) that was 10–1000 times
higher than that of the pellet fraction (Table 3). Other
combinations that showed good solubilization, such as TFIP
 LDAO  NFBSA or isooctane  AOT, carried approx-
imately equal amounts of infectivity in the supernatant and
pellet fractions. Experiments using the solvent HFPIP either
in combination with detergent or alone (Fig. 1 B) invariably
abolished scrapie infectivity.
Treatment with organic solvents and detergents not only
changed the aggregation state of PrP 27-30, but it also
modified its resistance to PK digestion (Fig. 5). The control
pellet and PrP 27-30 treated by TFIP alone remained resis-
tant to PK digestion. Supernatant fractions containing PrP
27-30 treated with HFPIP, APFO, or a combination of both
lost all resistance to PK digestion, while PrP 27-30 treated
with AOT and combinations of AOT and TFIP showed a
substantial reduction in resistance to PK digestion (Fig. 5).
Although disaggregation of PrP 27-30 was generally ac-
companied by a diminution in the resistance of the protein
to digestion by PK, the exceptions to this rule are most
important. Even partial disaggregation, as seen with HFPIP
or APFO (see Fig. 2), led to a reduction in PK resistance.
However, treatment with TFIP disrupted PrP 27-30 aggre-
gates without reducing PK resistance, showing that the
aggregation state does not always correlate with PK resis-
tance (Figs. 2 and 5). Bioassays showed that prion rods
treated with APFO retained full infectivity, while samples
treated with HFPIP or a combination of APFO and HFPIP
lost infectivity (Table 3). That these three conditions abolish
PK resistance equally well (Fig. 5) but have different effects
on scrapie infectivity demonstrates that PK resistance is not
required for preservation of prion infectivity. This finding is
in accord with other studies on transgenic mice expressing
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the P101L mutation that generates infectivity spontaneously
(Hsiao et al., 1994; Telling et al., 1996a) and on a PK-
sensitive fraction of PrPSc that correlates with the length of
the incubation period (Safar et al., 1998).
Sedimentation coefficients of solubilized PrP
We performed sucrose gradient centrifugation to determine
the molecular size and aggregation state of solubilized PrP
27-30. The high density of TFIP made it necessary to dilute
PrP 27-30 samples with aqueous buffer. This step led, most
likely, to a reextraction of the protein into the aqueous phase
since no phase separation was present after dilution. A
standard gradient with 5–20% sucrose without addition of
either detergent or solvent led to a complete reaggregation
during centrifugation (data not shown). The addition of 1%
TFIP and 0.5% AOT to the gradient allowed PrP 27-30 to
remain soluble and to migrate according to its size, shape,
and density (Fig. 6 A). Calculation of the S20,w values
revealed that the majority of solubilized PrP 27-30 migrated
as monomers of 2 S, and a small fraction of the protein
migrated around 4 S, which corresponds to PrP 27-30
FIGURE 3 Electron microscopy on two- and three-dimensional crystals of PrP 27-30. (A) Small three-dimensional crystals of PrP 27-30 solubilized by
20% TFIP  1% AOT with a hexagonal pattern. (B) Two-dimensional crystals of PrP 27-30 solubilized by 20% TFIP  1% AOT. (C) Untilted electron
micrograph of a small three-dimensional crystal similar to (A). (D) Same crystal as in (C) but tilted by 28°. A two-dimensional crystal lattice could be seen
after tilting, indicating that two-dimensional crystals seem to seed the three-dimensional ones. (E) Two- and three-dimensional crystals of PrP 27-30
solubilized by 10% HFPIP  1% AOT  1% APFO. These crystals were grown by using unbuffered 2% uranyl acetate solution. (F) Two- and
three-dimensional crystals of PrP 27-30 solubilized by 20% isooctane  2% AOT grown with buffered uranyl acetate pH 4.0. Three different lattices can
be observed. Bar  100 nm.
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dimers. The pelleted PrP 27-30 had a sedimentation coef-
ficient of 
8 S. An independent confirmation of the S20,w
values calculated from the first set of sucrose gradients was
obtained by use of standard proteins such as ribonuclease A
and ovalbumin. S20,w values calculated from these gradients
(Fig. 6 B) matched those calculated without the use of
calibrated proteins (Fig. 6 A); thus, we were able to calcu-
late the sedimentation coefficients by two independent
methods.
Bioassays of fractions from three independent sucrose
gradients revealed that prion infectivity could be found only
in the pellet fractions (Fig. 6 C). All scrapie prion infectivity
that was loaded onto the gradients, as determined by sepa-
rate bioassays, was recovered in the pellets, showing that
only 10% of PrP 27-30 accounted for all infectious units
while the remaining 90% could be separated from infectiv-
ity (Fig. 6). Ultracentrifugation without solvent or detergent
in the gradient (see above) led to reaggregation and pellet-
ing of PrP 27-30, and all of the infectivity that remained
after solubilization was found in the pellet as well. Negative
staining did not show protein aggregates in the peak frac-
tions of monomeric and dimeric PrP (Fig. 6, D and E). The
pellet fraction contained a small number of PrP aggregates
showing morphological features of prion rods (Fig. 6 F)
indicating the PrP 27-30 had not been solubilized.
FTIR spectroscopy
Previously, we observed that PrP 27-30 sustained a sizable
reduction in -sheet structure upon exposure to -helix-
promoting solvents such as HFIP or TFIP (Wille et al.,
1996). Those studies were carried out in the presence of
high concentrations of sucrose because of experimental
constraints. Here, to our surprise, we found that the -sheet
content remained almost constant throughout treatments
with either detergents or solvents (Table 4). Only a combi-
nation of detergent and solvent with sucrose (15% TFIP 
1% AOT  12.5% sucrose) showed a significant decrease
in -sheet structure. This shift from -sheet to -helix was
similar to the change observed in our earlier study indicat-
ing that sucrose is an essential component for this confor-
mational transition. PrP 27-30 solubilized by HFPIP 
AOT APFO could not be analyzed by FTIR spectroscopy
because of uninterpretable variations in absorption patterns
(data not shown).
DISCUSSION
Although the insolubility of prion infectivity in nondena-
turing detergents has been a persistent problem (Millson et
al., 1976; Prusiner et al., 1978), it was used to enrich
fractions from Syrian hamster brain that led to the discovery
of PrP 27-30 (Bolton et al., 1982; Prusiner et al., 1982). The
hydrophobic nature of prions and their close association
with membranes complicated efforts to obtain purified prep-
arations (Kimberlin et al., 1971; Malone et al., 1978; Marsh
et al., 1984; Millson et al., 1971; Semancik et al., 1976).
Even after PrPSc was discovered, it proved difficult to
release PrPSc from its association with membranes (Safar et
al., 1991).
Dispersion of PrP 27-30 into DLPCs increased the prion
titer by as much as 10-fold (Gabizon et al., 1987, 1988), but
the lipids interfered with crystallization and many biophys-
ical methods of analysis, rendering this procedure imprac-
tical. Intermediate concentrations of GdnHCl (1.5–4.5 M)
allowed a moderate level of solubilization (Safar et al.,
1993) but again did not permit crystallographic studies.
More recently, use of 0.2% SDS and sonication led to
TABLE 2 Electron diffraction data on PrP 27-30 crystals prepared with uranyl salts
Solubilization fraction Crystals Electron diffraction results
15% TFIP supernatant 2 2D crystals 4.0–3.9 nm on both axes, 68°–70° angle
1% AOT 3D crystals 3.7 nm, hexagonal array higher-order
reflections at 2.2 nm and 1.85 nm
15% TFIP supernatant 2 Same as above
1% AOT
25% sucrose
10% HFPIP supernatant 2 2D/3D crystals 3.5 nm and 3.0 nm, 68° angle
1% AOT
1% APFO
5% HFPIP supernatant 2 Crystals too small for electron diffraction
1% AOT
25% Sucrose
15% TFIP supernatant 2 Crystals too small for electron diffraction
1% LDAO
2.5% NFBSA
20% Isooctane supernatant 1 3D crystals
2% AOT type I 5.0 nm and 3.1 nm, 71°/109° angle, Fig. 4 A
type II 8.7 nm, 4.35 nm, and 5.1 nm, 29° angle, Fig. 4 B
type III 9.1 nm, hexagonal array
higher-order reflections at 5.0 nm, Fig. 4 C
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FIGURE 4 Electron micrographs and electron diffractograms of PrP 27-30 crystals. PrP 27-30 was solubilized by 20% isooctane  2% AOT, crystals
were grown from supernatant 1 by use of buffered uranyl acetate pH 4.0. Crystals with three different lattices were analyzed by electron diffraction. The
distances of the diffraction spots are given in nanometers. Bar  100 nm.
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disaggregation of PrP 27-30 into small spherical particles
with a relatively homogeneous size distribution of 10 nm
and a S20,w value of 6 S (Riesner et al., 1996), but this
procedure failed to produce monomers or dimers of PrP
27-30.
From previous investigations using -helix-promoting
solvents, we surmised that these solvents might have the
potential to disaggregate prion rods (Wille et al., 1996). In
the study reported here, we learned that neither organic
solvents nor nondenaturing detergents alone were sufficient
to solubilize PrP 27-30 (Fig. 1 and Table 1). Although many
membrane proteins can be solubilized by mild non-ionic
detergents, they have been found to lose activity when
stronger ionic detergents are used. In the case of prions, the
polymers of PrP 27-30 were found to withstand even the
most potent ionic detergents. Only combinations of one or
more detergents and organic solvents showed substantial
solubilization of PrP 27-30 (Fig. 1 and Table 1).
Solubilization of PrP via reverse micelles
Although solubilization is generally monitored by ultracen-
trifugation at 100,000  g for 1 h, this proved to be
inadequate for monitoring solubilization of PrP 27-30
(Riesner et al., 1996). In many cases, negative stain electron
microscopy revealed the presence of protein aggregates in
supernatant fractions (Fig. 2), so we regularly performed
negative staining on 100,000  g supernatant fractions.
Since solubilization with a high yield was achieved only
when a phase separation into two liquid phases occurred, we
suspected a solubilization mechanism involving reverse mi-
celles. The pH dependency of solubilization by reverse
micelles that had been observed for proteins such as ribo-
nuclease A, cytochrome C, and elastase (Go¨klen and Hat-
ton, 1987; Wolbert et al., 1989) suggested an approach to
optimize the solubilization further by increasing the pH to a
value just below the IEP of PrP 27-30. A conventional
TABLE 3 Scrapie infectivity of PrP 27-30 after solubilization
Assay conditions
Titer log ID50/ml (n/n0)*
Experiment 1 Experiment 2 Experiment 3 Experiment 4 Experiment 5
PrP 27-30, untreated control 7.5 (4/4) 8.2 (4/4) 8.8 (4/4) 9.3 (4/4) 8.7 (4/4)
PrP 27-30 buffer control pellet 6.7 (4/4) 8.3 (4/4) 9.4 (4/4) 9.3 (4/4) 8.7 (4/4)
supernatant 1.8 (1/4) 3.8 (4/4) 3.2 (3/4) 3.7 (4/4) 4.6 (4/4)
PrP 27-30  15% TFIP pellet 6.4 (4/4) n.d.# 7.5 (4/4) 8.4 (4/4) n.d.
supernatant 1 n.d. n.d. 4.3 (4/4) 2.7 (3/4) n.d.
supernatant 2 3.3 (2/4) n.d. 7.8 (4/4) 7.1 (4/4) n.d.
PrP 27-30  1% AOT pellet 6.7 (4/4) n.d. 9.1 (4/4) 9.3 (4/4) n.d.
supernatant 1 n.d. n.d. 5.7 (4/4) 7.2 (4/4) n.d.
supernatant 2 7.8 (4/4) n.d. 9.4 (4/4) 9.3 (4/4) n.d.
PrP 27-30  15% TFIP pellet 3.1 (2/4) 5.2 (4/4) 6.2 (4/4) 6.2 (4/4) n.d.
 1% AOT supernatant 1 n.d. 2.5 (4/4) 2.6 (4/4) 3.3 (4/4) n.d.
 25% sucrose supernatant 2 6.2 (4/4) 8.2 (4/4) 7.2 (4/4) 7.2 (4/4) n.d.
PrP 27-30  10% HFPIP pellet 1 (0/4) n.d. 1.3 (1/4) 1 (0/4) n.d.
supernatant 1 n.d. n.d. 1 (0/4) 1.7 (2/4) n.d.
supernatant 2 1 (0/4) n.d. 3.7 (4/4) 7.4 (3/4) n.d.
PrP 27-30  1% APFO pellet n.d. n.d. 9.0 (4/4) 10.0 (4/4) n.d.
supernatant n.d. n.d. 8.0 (4/4) 7.1 (4/4) n.d.
PrP 27-30  10% HFPIP pellet n.d. 1 (0/4) 1 (0/4) 1 (0/4) n.d.
 1% AOT supernatant 1 n.d. 1 (0/4) 1 (0/4) 1 (0/4) n.d.
 1% APFO supernatant 2 n.d. 1 (0/4) 1 (0/4) 1 (0/4) n.d.
PrP 27-30  15% TFIP pellet 3.1 (3/4) 5.8 (4/4) n.d. n.d. n.d.
 1% saponin supernatant 1 n.d. n.d. n.d. n.d. n.d.
supernatant 2 6.7 (4/4) 6.9 (4/4) n.d. n.d. n.d.
PrP 27-30  10% HFPIP pellet 1 (0/4) 2.7 (4/4) n.d. n.d. n.d.
 1% saponin supernatant 1 n.d. 1 (0/4) n.d. n.d. n.d.
supernatant 2 1 (0/4) 1 (0/4) n.d. n.d. n.d.
PrP 27-30  1% LDAO pellet n.d. 7.4 (4/4) n.d. n.d. n.d.
 2% NFBSA supernatant n.d. 7.4 (4/4) n.d. n.d. n.d.
PrP 27-30  15% TFIP pellet n.d. 6.6 (4/4) n.d. n.d. n.d.
 1% LDAO supernatant 1 n.d. n.d. n.d. n.d. n.d.
 2% NFBSA supernatant 2 n.d. 7.3 (4/4) n.d. n.d. n.d.
PrP 27-30  20% isooctane pellet n.d. n.d. n.d. n.d. 8.0 (4/4)
supernatant 1 n.d. n.d. n.d. n.d. 4.6 (4/4)
supernatant 2 n.d. n.d. n.d. n.d. 4.9 (4/4)
PrP 27-30  20% isooctane pellet n.d. n.d. n.d. n.d. 7.3 (4/4)
 2% AOT supernatant 1 n.d. n.d. n.d. n.d. 7.4 (4/4)
supernatant 2 n.d. n.d. n.d. n.d. 7.4 (4/4)
*n/n0, number of sick animals/number of inoculated animals.
#n.d., not determined.
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solubilization mechanism would require a pH distinctly
different from the IEP. The limited solubilization that was
achieved using 2.5% NFBSA in 1% LDAO showed this
type of pH dependency, implying that a conventional mech-
anism of solubilization might be occurring with this com-
bination (data not shown).
The solubilization capacity of AOT reverse micelles is
influenced by cosolvents and cosurfactants, which can in-
clude autohydrolysis products (Fletcher et al., 1982; Rabie
et al., 1997). One AOT hydrolysis product, 2-ethylhexanol,
reduces the solubilization yield in the system isooctane 
AOT but not with TFIP  AOT. Substoichiometric
amounts of 2-ethylhexanol improve the solubility of AOT
monomers in apolar solvents, such as isooctane, and thereby
effectively reduce the concentration of solubilization-com-
petent reverse micelles. Another AOT hydrolysis product,
sulfosuccinic acid, increases solubilization in isooctane 
AOT by salting AOT out of the aqueous phase and into the
organic phase, and hence elevates the concentration of re-
verse micelles (Fletcher et al., 1982; Rabie et al., 1997).
TFIP as an alcohol behaves differently from the usually
employed solvents and thereby makes this solubilization
system much less vulnerable to chemical impurities and
physical disturbances.
In summary, we think PrP 27-30 was solubilized into
reverse micelles based on the following observations: 1) the
majority of PrP 27-30 could be found in the organic phase
only (Fig. 1); 2) conditions that did not separate into an
aqueous and organic phase yielded little or no solubilization
(Table 1); 3) the solubilization showed an optimum at about
one pH unit below the IEP of PrP 27-30, well in accordance
with other reverse micellar systems; and 4) dynamic light
scattering revealed the presence of water-filled reverse mi-
celles in the solubilization controls and a mixed population
of protein- and water-filled reverse micelles when PrP
27-30 was used.
Limitations of spectroscopy
FTIR spectroscopy of solubilized PrP 27-30 showed that in
most cases, the -sheet content had not been reduced de-
spite the use of an -helix-promoting solvent such as TFIP
(Gasset et al., 1993; Wille et al., 1996). We initially ex-
pected that TFIP might solubilize PrP 27-30 because we had
previously shown that it partially disperses prion rods by
reducing the -sheet content without affecting scrapie in-
fectivity. Those studies were done in the presence of 50%
sucrose (Wille et al., 1996). The FTIR spectroscopy results
we obtained when using 15% TFIP  1% AOT  25%
sucrose clearly show it was the sucrose that enabled TFIP to
promote -helical structure, presumably by increasing the
solvent polarity to such an extent that TFIP interacted with
PrP 27-30 more strongly than without sucrose. However,
AOT reverse micelles have been demonstrated to decrease
the amount of secondary and tertiary structure by favoring
extended conformations in proteins such as -chymotrypsin
and cytochrome C (Adachi and Harada, 1994; Qinglong et
al., 1994). A similar tendency could protect the -sheet
structure in PrP 27-30 against the influences of TFIP.
Crystallization of PrP 27-30
The crystallization of membrane and membrane-associated
proteins is generally difficult, but membrane proteins have
a high propensity to form two-dimensional crystals by lat-
eral association inside the lipophilic milieu of natural and
synthetic membranes. Factors influencing the crystallization
processes in two and three dimensions have been studied in
great detail (for reviews see Dolder et al., 1996; Glaeser and
Downing, 1993; Michel, 1991).
The crystallization of solubilized PrP 27-30 depended on
the use of uranyl salts as a crystallization reagent. AOT
reverse micelles have a high propensity to bind monovalent,
divalent, and trivalent metal ions effecting a decreased
micelle size with increasing ionic valence (Sugimura et al.,
1992). Uranyl ions, although not included in the study of
Sugimura and co-workers, should tightly bind to AOT re-
verse micelles owing to their doubly negative charge. This
would decrease the micellar size and enable PrP 27-30
molecules to make the contacts necessary for crystal forma-
tion. Uranyl ions bind more tightly to SDS micelles than
other divalent cations (Reiller et al., 1994); a similar behav-
ior could be expected for AOT reverse micelles and might
explain why only the uranyl ion allowed crystal growth.
Additionally, the unique linear structure of the f-block ura-
FIGURE 5 Western blots of PK assays on PrP 27-30 after solubilization.
The supernatants after solubilization by various agents were incubated with
PK for 2 h at 37°C. Solubilization by 10% HFPIP, 1% APFO, 10%
HFPIP  1% AOT  1% APFO, or 15% TFIP  1% AOT  12.5%
sucrose almost completely abolished PK resistance in PrP 27-30. Treat-
ment by 1% AOT or 20% TFIP  1% AOT reduced PK resistance, while
15% TFIP alone had no significant effect.
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nyl ion makes a replacement by other metal ions seem
unlikely.
The role of divalent uranyl ions
A likely explanation for the pH dependency of PrP 27-30
crystallization is the pH-dependent stability of the uranyl
ion. At pH 4.0, 96% of the uranyl ions are present as
divalent UO2
2 cations and only 4% as monovalent
UO2(OH)
; at pH 5.0, UO2
2 is present only at 70% while
the UO2(OH)
 concentration increases to 30% (Moulin et
al., 1995). We assume that the monovalent UO2(OH)

competes for the binding to the detergent or protein, or
possibly both, and thereby inhibits the formation of PrP
27-30 crystals. The observation of unusually strong reflec-
tions at 3.1 nm in the electron diffractograms of PrP 27-30
crystallized from 20% isooctane  2% AOT (Fig. 4 A)
supports the notion that a complex of PrP 27-30, AOT, and
uranyl ions is responsible for the crystallization process.
The failure to obtain crystals in the presence of citric acid as
a buffer probably stems from the formation of very stable
complexes between the uranyl and citrate ions (Abdel Razik
et al., 1989), again arguing that uranyl ions are needed to
form complexes with PrP 27-30 and the detergent in order
for crystals to grow.
Crystallization from a reverse micellar solution
To our knowledge, crystallization of PrP 27-30 from reverse
micelles is the first example of the use of such a system to
crystallize a membrane protein. Previous work by Wirz and
Rosenbusch (1984) mentions attempts to crystallize bacte-
rial porins from reverse micelles, but no reports of success-
ful crystallization followed. A bicontinuous cubic phase,
which may be seen as an intermediary between a reverse
micellar phase and an aqueous phase with micelles, has
FIGURE 6 Sucrose gradient centrifugation of PrP 27-30 solubilized by 20% TFIP  1% AOT. (A) Solubilized PrP 27-30 was subjected to
ultracentrifugation in a 5–20% sucrose gradient. The peak of PrP 27-30 content (fractions 5–8) corresponds to monomeric protein with a S20,w value of
2 S. A second peak containing less protein (fractions 9–11) corresponds to dimeric PrP 27-30, 4 S. A relatively faint band of aggregates with 
8 S
could be seen in the pellet (fraction 16). (B) A sample of solubilized PrP 27-30 was mixed with small amounts of ribonuclease A and ovalbumin. A
Coomassie-stained SDS PAGE shows the peak of ribonuclease A in fractions 5 and 6 and the peak of ovalbumin in fractions 8 and 9. Sedimentation
coefficients for ribonuclease A and ovalbumin from this centrifugation run agree well with published data. The S20,w value of the monomeric PrP 27-30
calculated by comparison to the S20,w values of the ribonuclease A and ovalbumin concurs with the one calculated directly from the sucrose gradient
centrifugation. (C) Bioassays of the sucrose gradient fractions showed that scrapie infectivity (dashed line) could be found only in the pellet fractions
containing protein aggregates larger than 8 S, neither PrP 27-30 monomers (fractions 5–8) nor dimers (fractions 8–10) showed significant infectivity. Both
curves show the average of three independent experiments. The titer of solubilized PrP 27-30 before the sucrose gradients (diamond on the far left) and
that of the pellet fraction (number 16) were reasonably similar to infer that all infectivity after solubilization resided in the remaining protein aggregates.
All other fractions were below or close to the detection limit of one infectious unit/ml. Negative stain electron microscopy of (D) the peak fraction of
monomeric PrP 27-30 and (E) dimeric PrP 27-30 showed no residual protein aggregates. (F) The pellet fraction revealed small aggregates that apparently
withstood the solubilization. The appearance of the aggregates is reminiscent of untreated prion rods (compare Fig. 2 A). Negative stain 2% ammonium
molybdate, bar  100 nm.
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recently been shown to allow three-dimensional crystalliza-
tion of bacteriorhodopsin (Landau and Rosenbusch, 1996;
Pebay-Peyroula et al., 1997). The crystallization of PrP
27-30 may occur through the formation of a bicontinuous
cubic phase during the treatment with uranyl salts (but in
our case from a reverse micellar system) or may be the
result of a reextraction of PrP 27-30 from reverse micelles.
AOT complexes with other divalent cations such as cad-
mium, cobalt, or copper show multiple phases, one being
bicontinuous (Petit et al., 1991). A different set of mono and
divalent cations such as lithium, beryllium, and magnesium
was found to inhibit the formation of AOT reverse micelles
(Rabie and Vera, 1997). To our knowledge, no studies of
AOT with uranyl ions have been published, leaving the
question about the underlying mechanism open to specula-
tion. In either case, it remains to be established whether the
crystals we obtained will be suitable for high-resolution
diffraction studies. The principal observation that mem-
brane protein crystals can be grown from a reverse micellar
solution may prove to be applicable for the crystallization of
other membrane proteins.
The nature of the crystallization method and the mul-
tiphasic behavior of detergents such as AOT, especially at
reduced water contents, increases the possibility of artifacts,
which is a potential problem. An AOT bicontinuous cubic
phase showed periodicities in x-ray diffractograms of 2.8
nm, 2.5 nm, 1.9 nm, etc.; the hexagonal phase gives reflec-
tions that begin at 2.4–3 nm, depending on water content
(Ekwall et al., 1970). These diffractograms were obtained
from pure AOT; the addition of cations other than Na
(particularly multivalent cations) should reduce the lattice
spacings by shielding the charges on the AOT molecules
similar to what is seen in the liquid reverse micellar state
(Petit et al., 1991). Since our lattice spacings are 4 nm for
the two-dimensional crystals and 3.7 nm for the hexagonal
arrays, this leaves enough room for PrP 27-30 to be included
in the crystalline array. Uranyl acetate and two unrelated
detergents (sodium 4-(1-heptylnonyl)benzenesulfonate and
sodium octanoate) give crystalline aggregates with a lamel-
lar character and corresponding one-dimensional electron
diffraction patterns (Kilpatrick et al., 1985). Uranyl acetate
negative stains on AOT and Li-AOT showed only micelles
and liposome-like structures; no crystalline arrays were
observed (Karaman et al., 1994). From these studies and our
own efforts to obtain crystalline aggregates from uranyl
acetate and AOT alone with or without the presence of TFIP
or isooctane, we conclude that the observed crystals are
most likely cocrystals of PrP 27-30, AOT, and uranyl ions.
CONCLUDING REMARKS
The solubilization of PrP 27-30 into a reverse micellar
solution produces monomeric and dimeric PrP that forms
small two- and three-dimensional crystals. Why do the
monomers and dimers not possess scrapie infectivity? One
possibility is that the monomer and dimer formation was
accompanied by partial denaturation, and thus conditions
for solubilization of biologic activity still need to be iden-
tified. This contention is supported by studies on other
proteins noted above, where AOT reverse micelles de-
creased the amount of secondary and tertiary structure fa-
voring extended conformations of the proteins (Adachi and
Harada, 1994; Qinglong et al., 1994). Another possibility is
TABLE 4 Secondary structure of PrP 27-30 after treatment with organic solvents, detergents, and combinations
Treatment
Secondary structure (%)
-Helix -Sheet Turns Coil
PrP 27-30
in PBSZ* 23 48 9 20
in 25% sucrose* 27 43 13 17
in 25% sucrose  10% TFIP* 40 28 12 20
Solubilization
PrP 27-30
 buffer only (control) pellet 24 41 9 26
 1% AOT pellet 26 44 14 16
 1% APFO pellet 14 55 25 6
 1% saponin pellet 17 57 5 21
 20% TFIP pellet# 22 54 7 17
 20% TFIP mixture 30 40 10 20
 10% HFPIP pellet# 21 48 7 24
 10% HFPIP mixture 38 32 10 20
 20% isooctane mixture 26 46 7 21
 20% TFIP, 1% AOT supernatant 2 18 52 7 23
 15% TFIP, 1% AOT, 12.5% sucrose supernatant 2 40 25 13 22
 15% TFIP, 1% saponin supernatant 2 22 51 10 17
 20% isooctane, 2% AOT supernatant 1 24 54 8 14
*Data taken from Wille et al. (1996).
#Actually a mixture of pellet and supernatant 2.
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that monomers and dimers are more readily cleared from the
CNS after inoculation than are large aggregates, which are
more protected from degradation by tissue proteases
(Prusiner et al., 1998; Safar et al., 1998).
To our knowledge, this is the first description of crystals
of a -sheet-rich PrP derived from PrP 27-30; moreover, it
may be the first demonstration of the crystallization of a
membrane or membrane-associated protein directly from a
reverse micellar system. The PrP crystals appear to be
suitable for structural analysis by electron crystallography.
Indeed, if larger three-dimensional crystals of PrP 27-30 can
be formed, then it may be possible to determine the structure
of the protein by x-ray crystallography.
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